The Added Value of Transcranial Direct Current Stimulation (tDCS) During Exercise for People With Chronic Widespread Pain
RecruitingNot applicableNCT07212829
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Many people with chronic widespread pain (CWP) feel more pain and fatigue after exercise. This makes it hard to stay active. Unfortunately, the investigators do not fully understand why this happens and how to prevent it. The primary goal of this study is to explore the underlying genetic and epigenetic mechanisms of BDNF gene in response to exercise, and investigate if transcranial direct current stimulation (tDCS) during exercise works to improve worsening symptoms response to exercise in people with CWP. The investigators designed a randomized crossover study and will enroll 60 patients with CWP and 60 healthy controls. Participants will undergo 2 interventions in random order: 1) exercise + active tDCS, and 2) exercise + sham tDCS. Participants will visit the hospital twice with at least one week in between the visits.
Study details
- Official title
- Unravelling the Epigenetic Mechanisms of Exercise-induced Pain in Chronic Widespread Pain: DNA Methylation Regulation of the Brain-derived Neurotrophic Factor Expression and Its Modulation by Transcranial Direct Current Stimulation
- Conditions
- Sponsor
- Vrije Universiteit Brussel
- Start date
- 2026-02-01
- Primary completion
- 2027-12-30
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Belgium
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Patients Participants in the patient group must meet all of the following criteria: 1. Diagnosis of chronic widespread pain (CWP) or fibromyalgia; 2. Age between 18 and 70 years old; 3. Body mass index (BMI) ≤ 35; 4. Widespread Pain Index (WPI) assessment: the WPI questionnaire (0-19 points) will be used to record the number and distribution of painful body sites. Participants will be classified as having CWP if pain is reported on both sides of the body, above and below the waist, and in the axial skeleton, with pain symptoms lasting ≥ 3 months; 5. Stable medication use for at least 1 month prior to study entry. Healthy control group Participants in the healthy control group must meet all of the following criteria: 1. Age between 18 and 70 years old; 2. Body mass index (BMI) ≤ 35; 3. No chronic conditions, such as chronic pain and diabetes. Exclusion Criteria: For both patients and healthy controls, participants will be excluded if they meet any of the following: 1. Current pregnancy or pregnancy within the past 12 months; 2. Contraindications for non-invasive brain stimulation (NIBS), in line with published safety guidelines; 3. History of neurological disorders, including epilepsy (personal or family history), traumatic brain injury, stroke, dementia, or Parkinson's disease; 4. Major medical conditions, including cancer, endocrine or metabolic disorders, urine, genital and cardiovascu-lar diseases (e.g., myocardial infarction, heart failure, arrhythmia, uncontrolled hypertension). 5. Substance abuse. 6. Presence of psychiatric disorders other than depression or anxiety.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07212829